- AVF Academy
- Get Out the Clot: Closing the Gaps That Cost Lives
Mark Iafrati, MDPresident, The American Venous Forum
The Get Out the Clot campaign launched in 2024 to unite leading organizations and medical experts to address the ongoing gaps in venous thromboembolism (VTE) care. Approximately 900,000 people in the United States are affected by VTE each year, and between 60,000 and 100,000 die from it. Despite advances in prevention and treatment, gaps remain in awareness, diagnosis, and standardized management among both patients and healthcare providers. Over the past two years, the campaign has worked to close those gaps.
A closer look at the disparities in care
A white paper, developed in collaboration with Becker’s Healthcare, highlights expert insights around where VTE care falls short and what needs to change. Key themes include earlier recognition of VTE signs and symptoms, greater adoption of evidence-based treatment pathways, and emerging technologies that may improve outcomes for patients with acute clot burden. Read VTE Care at the Crossroads: Today’s Challenges and Tomorrow’s Breakthroughs here.
Spreading awareness of VTE symptoms
Get Out the Clot is also focused on helping the public recognize VTE symptoms before serious complications occur. This CBS News story follows Elizabeth Simms, a 27-year-old who was 31- weeks pregnant when she suddenly couldn’t catch her breath. She initially thought her symptoms were due to her pregnancy, but it turned out to be a life-threatening pulmonary embolism. Thanks to the quick actions of her medical team, who leveraged a computer-assisted vacuum thrombectomy device (CAVT) to remove the blood clot, she made a full recovery. Her story is a powerful reminder that VTE symptoms, like sudden shortness of breath or chest pain, are always worth taking seriously, especially during pregnancy, when the risk is higher.
Get Out the Clot is a collaborative educational initiative uniting American Venous Forum, International Society on Thrombosis and Haemostasis, National Blood Clot Alliance, Penumbra, The PERT Consortium®, and Society for Vascular Medicine. As the campaign continues, its focus remains on promoting earlier recognition, more consistent care pathways, and improved outcomes for patients at risk for VTE.




